Switching from febuxostat to dotinurad, a novel selective urate reabsorption inhibitor, may substantially reduce serum urate levels, through URAT1 inhibition, potentially without adversely affecting ABCG2 function: findings from the SWITCH SURI study
Takeshi Osonoi(Centre for Advanced Study), Makoto Katoh(Kinan Hospital)
Cited by 2